Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) is -1.33% lower on its value in year-to-date trading and has touched a low of $0.31 and a high of $4.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CYCC stock was last observed hovering at around $0.35 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $0.37, the stock is -1.74% and -1.59% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.43 million and changing 6.00% at the moment leaves the stock -69.33% off its SMA200. CYCC registered -82.82% loss for a year compared to 6-month loss of -77.92%. The firm has a 50-day simple moving average (SMA 50) of $0.3772 and a 200-day simple moving average (SMA200) of $1.2099.
The stock witnessed a 16.89% gain in the last 1 month and extending the period to 3 months gives it a -74.06%, and is 5.28% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.60% over the week and 16.79% over the month.
Profit margin for the company is -18217.57%. Distance from 52-week low is 19.64% and -90.73% from its 52-week high.
.
Cyclacel Pharmaceuticals Inc (CYCC) Top Institutional Holders
19.0 institutions hold shares in Cyclacel Pharmaceuticals Inc (CYCC), with institutional investors hold 18.94% of the company’s shares. The shares outstanding are 11.26M, and float is at 10.93M with Short Float at 1.23%. Institutions hold 18.03% of the Float.
Cyclacel Pharmaceuticals Inc (CYCC) Insider Activity
#####
